Afferent Pharmaceuticals
San Mateo, US · Delaware corporation · 2 known investors
Biotech
Founders & leadership
AF
Anthony FordFounder
MK
Michael KittExecutive
KS
Kathleen Sereda GlaubExecutive
Board
KS
AP
Arthur PappasBoard director
LR
Liam RatcliffeBoard director
JT
PH
Peter HirthBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$55M disclosed across 1 round · 2015
▶$55MraisedJul 2015 · 17 investors · PharmaceuticalsRule 506(b)
▶$55MraisedJul 2015 · 17 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kevin StarrDirector
- Michael KittExecutive Officer
- Arthur PappasDirector
- Anthony FordExecutive Officer
- Kathleen Sereda GlaubExecutive Officer, Director
- Peter HirthDirector
- Liam RatcliffeDirector
- Jesse TreuDirector
- Offering amount
- $55M
- Amount sold
- $55M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Afferent Pharmaceuticals?
- Afferent Pharmaceuticals was founded by Anthony Ford.
- Who are Afferent Pharmaceuticals's investors?
- Afferent Pharmaceuticals's investors include Domain Associates, Third Rock Ventures.
- How much funding has Afferent Pharmaceuticals raised?
- Afferent Pharmaceuticals has disclosed $55M raised across 1 round.
- Where is Afferent Pharmaceuticals headquartered?
- Afferent Pharmaceuticals is headquartered in San Mateo, US.